Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1437173A (Shingrix) dose-finding study in healthy elderly for Herpes Zoster prevention
NCT00434577Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2007
- Primary completion
- Oct 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 2 trial of herpes zoster vaccine (recombinant, adjuvanted) in herpes zoster (HZ), sponsored by GSK. Started Feb 2007; status: completed.
02
Drugs
herpes zoster vaccine (recombinant, adjuvanted)
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT00434577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434577.